Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. - Angelopoulou MK; Vassilakopoulos TP; Batsis I; Sakellari I; Gkirkas K; Pappa V; Giannoulia P; Apostolidis I; Apostolopoulos C; Roussou P; Panayiotidis P; Dimou M; et al. (Hematological oncology, 2018)